Risk factors for adverse cardiac events in adults with fulminant myocarditis during hospitalization.

World J Clin Cases

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Lab for Cardiovascular Precision Medicine, Beijing 100029, China.

Published: January 2020

Background: Fulminant myocarditis is the critical form of myocarditis that is often associated with heart failure, malignant arrhythmia, and circulatory failure. Patients with fulminant myocarditis who end up with severe multiple organic failure and death are not rare.

Aim: To analyze the predictors of in-hospital major adverse cardiovascular events (MACE) in patients diagnosed with fulminant myocarditis.

Methods: We included a cohort of adult patients diagnosed with fulminant myocarditis who were admitted to Beijing Anzhen Hospital from January 2007 to December 2017. The primary endpoint was defined as in-hospital MACE, including death, cardiac arrest, cardiac shock, and ventricular fibrillation. Baseline demographics, clinical history, characteristics of electrocardiograph and ultrasonic cardiogram, laboratory examination, and treatment were recorded. Multivariable logistic regression was used to examine risk factors for in-hospital MACE, and the variables were subsequently assessed by the area under the receiver operating characteristic curve (AUC).

Results: The rate of in-hospital MACE was 40%. Multivariable logistic regression analysis revealed that baseline QRS duration > 120 ms was the independent risk factor for in-hospital MACE (odds ratio = 4.57, 95%CI: 1.23-16.94, = 0.023). The AUC of QRS duration > 120 ms for predicting in-hospital MACE was 0.683 (95%CI: 0.532-0.833, = 0.03).

Conclusion: Patients with fulminant myocarditis has a poor outcome. Baseline QRS duration is the independent risk factor for poor outcome in those patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000935PMC
http://dx.doi.org/10.12998/wjcc.v8.i2.255DOI Listing

Publication Analysis

Top Keywords

fulminant myocarditis
20
in-hospital mace
20
qrs duration
12
risk factors
8
patients fulminant
8
patients diagnosed
8
diagnosed fulminant
8
multivariable logistic
8
logistic regression
8
baseline qrs
8

Similar Publications

Background: Fulminant myocarditis (FM) is a critical manifestation of myocarditis. However, the clinical features and risk factors associated with its adverse outcomes are not fully understood. Given the high mortality and potential for long-term complications, it is crucial to identify factors that could predict the progression of FM to chronic persistent myocarditis.

View Article and Find Full Text PDF

Re-evaluation of intravenous steroid therapy for histologically confirmed fulminant myocarditis.

Int J Cardiol

March 2025

Department of Cardiovascular Medicine, Nara Medical University, Nara, Japan; Department of Cardiology, Nara Prefecture Seiwa Medical Center, Nara, Japan.

Background: The efficacy of intravenous steroids (IS) for fulminant myocarditis (FMP) remains controversial. We aimed to compare outcomes in FMP patients who received IS [IS(+)] and those who did not [IS(-)].

Methods And Results: Data from 344 patients with histologically confirmed FMP requiring catecholamines or mechanical support were extracted from the Japanese Registry of Fulminant Myocarditis.

View Article and Find Full Text PDF

Diphtheria is a contagious disease with high mortality. Although the global prevalence has been decreasing, the immigration of certain populations with suboptimal vaccination coverage has contributed to its resurgence in developed countries. We report a 16-year-old Afghan male with acute respiratory distress and life-threatening complications, including fulminant myocarditis with cardiac arrhythmias and neurologic complications.

View Article and Find Full Text PDF

Myocarditis diagnosis: From light microscope to molecular analysis and cardiac magnetic resonance.

Eur Heart J Suppl

February 2025

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Via A. Gabelli 61, Padova 35121, Italy.

Telling story of myocarditis is characterized by discoveries and inventions. The invention of the microscope opened new avenues in medicine, with the observation of myocardial inflammation by Carl Ludwig Alfred Fiedler. Rudolph Virchow discovered that cells are the elementary units.

View Article and Find Full Text PDF

Acute myocarditis: 2024 state of the art.

Eur Heart J Suppl

February 2025

De Gasperis Cardio Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.

Acute myocarditis (AM) is an inflammatory injury of the myocardium secondary to infections, systemic autoimmune disorders, medications, or toxic agents. The patient's genetic underground is a likely concurrent aetiology/contributory mechanism recently implicated in a proportion of AM. This review focuses on some critical new concepts of AM, updated indications for endomyocardial biopsy when cardiac magnetic resonance imaging is not sufficient or feasible, and estimation of long-term events after discharge.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!